Here's the pitch deck that Point72-backed Heidi Health used to raise $65 million to battle in the AI scribe race (www.businessinsider.com)

Heidi Health raised $65 million in a Series B led by Steve Cohen’s Point72 Private Investments, valuing the Australian healthcare AI startup at $465 million post-money and bringing total funding to about $97 million. The company offers a free core AI medical scribe (with a $70/month premium tier for personalized templates) and claims physician-driven adoption—roughly half of sales come from clinicians signing up directly—across 116 countries. Seven months after a $16.6M Series A that included Anthropic and Headline, Heidi also launched an automated patient-calling tool for follow-ups and scheduling, signaling a shift from pure documentation toward supervised task automation. Technically and strategically, Heidi’s “open plan” approach prioritizes clinician activation and customization over deep, standardized EHR integration—contrasting startups that pursue top-down deals with systems like Epic—and argues this reduces churn risk despite tradeoffs around documentation standardization and revenue-cycle capture. The firm plans to use the new capital to scale hiring in the US/UK/Canada and to build an AI medical search product to compete with OpenEvidence and Doximity, while drawing a clear privacy/monetization line by refusing pharma ads. The move highlights two broader implications for the AI/ML health community: ambient scribe tech is maturing into broader clinical automation, and market winners will need to balance integration, clinician trust, and monetization ethics.